SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 325 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,197,178 | +20.2% | 26,375 | +13.5% | 0.01% | 0.0% |
| Q2 2023 | $2,660,643 | +148.5% | 23,233 | +199.1% | 0.01% | +150.0% |
| Q1 2023 | $1,070,525 | +137.4% | 7,767 | +29.1% | 0.00% | – |
| Q2 2022 | $451,000 | -4.0% | 6,015 | 0.0% | 0.00% | – |
| Q1 2022 | $470,000 | -13.3% | 6,015 | 0.0% | 0.00% | – |
| Q4 2021 | $542,000 | -2.5% | 6,015 | 0.0% | 0.00% | – |
| Q3 2021 | $556,000 | -5.0% | 6,015 | -20.0% | 0.00% | – |
| Q2 2021 | $585,000 | -4.9% | 7,515 | -9.0% | 0.00% | -100.0% |
| Q1 2021 | $615,000 | -87.3% | 8,255 | -70.9% | 0.00% | -80.0% |
| Q4 2020 | $4,839,000 | +52.7% | 28,380 | +25.8% | 0.01% | +25.0% |
| Q3 2020 | $3,168,000 | -35.7% | 22,560 | -26.6% | 0.00% | -33.3% |
| Q2 2020 | $4,926,000 | +70.6% | 30,722 | +4.1% | 0.01% | +50.0% |
| Q1 2020 | $2,887,000 | -57.3% | 29,516 | -43.7% | 0.00% | -33.3% |
| Q4 2019 | $6,763,000 | +61.9% | 52,404 | -5.6% | 0.01% | +50.0% |
| Q3 2019 | $4,178,000 | -89.3% | 55,537 | -78.4% | 0.00% | -88.9% |
| Q2 2019 | $39,012,000 | +29.1% | 256,741 | +1.3% | 0.04% | +20.0% |
| Q1 2019 | $30,216,000 | +87.6% | 253,511 | +71.6% | 0.03% | +66.7% |
| Q4 2018 | $16,104,000 | +16.3% | 147,776 | +72.4% | 0.02% | +38.5% |
| Q3 2018 | $13,846,000 | +59.8% | 85,728 | +30.7% | 0.01% | +62.5% |
| Q2 2018 | $8,667,000 | +58.5% | 65,568 | -11.2% | 0.01% | +60.0% |
| Q1 2018 | $5,469,000 | +51.3% | 73,817 | +13.6% | 0.01% | +66.7% |
| Q4 2017 | $3,615,000 | +11.4% | 64,961 | -9.2% | 0.00% | 0.0% |
| Q3 2017 | $3,246,000 | +34.6% | 71,565 | -0.8% | 0.00% | +50.0% |
| Q2 2017 | $2,412,000 | +27.3% | 72,151 | +12.4% | 0.00% | 0.0% |
| Q1 2017 | $1,894,000 | +13.1% | 64,177 | +5.0% | 0.00% | 0.0% |
| Q4 2016 | $1,675,000 | +7.9% | 61,093 | -23.2% | 0.00% | 0.0% |
| Q1 2016 | $1,553,000 | -84.8% | 79,595 | -70.0% | 0.00% | -83.3% |
| Q4 2015 | $10,238,000 | +71.2% | 265,000 | +42.3% | 0.01% | +71.4% |
| Q3 2015 | $5,981,000 | +1907.0% | 186,265 | +1762.6% | 0.01% | – |
| Q2 2014 | $298,000 | +24.2% | 10,000 | 0.0% | 0.00% | – |
| Q1 2014 | $240,000 | -48.8% | 10,000 | -56.5% | 0.00% | -100.0% |
| Q4 2013 | $469,000 | -60.8% | 23,000 | -9.3% | 0.00% | -50.0% |
| Q3 2013 | $1,197,000 | -59.6% | 25,350 | -67.4% | 0.00% | -50.0% |
| Q2 2013 | $2,961,000 | – | 77,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |